Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Philip R. Deitiker, Minako Oshima, R. Glenn Smith, Dennis R. Mosier & M. Zouhair Atassi. (2006) Subtle differences in HLA DQ haplotype-associated presentation of AChR α-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity 39:4, pages 277-288.
Read now
Read now
Articles from other publishers (28)
Maria Salvado, Jose Luis Caro, Cecilia Garcia, Francesc Rudilla, Laura Zalba-Jadraque, Eva Lopez, Elia Sanjuan, Josep Gamez & Jose Manuel Vidal-Taboada. (2022) HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort. Neurological Sciences 43:8, pages 5057-5065.
Crossref
Crossref
Manuel Ruiz-Pablos. (2022) CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases. Pathogens 11:8, pages 831.
Crossref
Crossref
Güher Saruhan-Direskeneli & Amr H. Sawalha. 2019. Genetics of Rare Autoimmune Diseases. Genetics of Rare Autoimmune Diseases
203
219
.
Zena Wolf, Karen Vernau, Noa Safra, G. Diane Shelton, Jason King, Joseph Owen, Kalie Weich & Danika Bannasch. (2017) Association of early onset myasthenia gravis in Newfoundland dogs with the canine major histocompatibility complex class I. Neuromuscular Disorders 27:5, pages 409-416.
Crossref
Crossref
Güher Saruhan-Direskeneli, Travis Hughes, Vuslat Yilmaz, Hacer Durmus, Adam Adler, Mahdi Alahgholi-Hajibehzad, Fikret Aysal, Sibel P. Yentür, Mehmet Ali Akalin, Oner Dogan, Alexander Marx, Yesim Gülsen-Parman, Piraye Oflazer, Feza Deymeer & Amr H. Sawalha. (2016) Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clinical Immunology 166-167, pages 81-88.
Crossref
Crossref
Soroush Ehsan, Aliakbar Amirzargar, Mir Saeed Yekaninejad, Mahdi Mahmoudi, Saeed Mehravar, Batoul Moradi & Shahriar Nafissi. (2015) Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population. Journal of the Neurological Sciences 359:1-2, pages 335-342.
Crossref
Crossref
Mahdi Alahgholi-Hajibehzad, Vuslat Yilmaz, Yesim Gülsen-Parman, Fikret Aysal, Piraye Oflazer, Feza Deymeer & Güher Saruhan-Direskeneli. (2013) Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey. Human Immunology 74:12, pages 1633-1635.
Crossref
Crossref
Torres Sylvia, Morales Samuel, Gonzáles Luis & Martínez Zuzet. (2013) No association of the HLA-DQ alleles with myasthenia gravis in Cuban patients. Human Immunology 74:8, pages 983-985.
Crossref
Crossref
Angelina H. Maniaol, Ahmed Elsais, Åslaug R. Lorentzen, Jone F. Owe, Marte K. Viken, Hanne Sæther, Siri T. Flåm, Geir Bråthen, Margitta T. Kampman, Rune Midgard, Marte Christensen, Anna Rognerud, Emilia Kerty, Nils Erik Gilhus, Chantal M. E. Tallaksen, Benedicte A. Lie & Hanne F. Harbo. (2012) Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population. PLoS ONE 7:5, pages e36603.
Crossref
Crossref
Güher Saruhan-Direskeneli, Aylin Kiliç, Yeşim Parman, Piraye Serdaroğlu & Feza Deymeer. (2006) HLA-DQ Polymorphism in Turkish Patients With Myasthenia Gravis. Human Immunology 67:4-5, pages 352-358.
Crossref
Crossref
Minako Oshima, Philip R. Deitiker, Dennis R. Mosier, R. Glenn Smith & M. Zouhair Atassi. (2005) Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor α-chain peptides: Analysis in relation to age, thymic abnormality, and ethnicity. Human Immunology 66:1, pages 32-42.
Crossref
Crossref
Ann Kari Lefvert. 2005. Molecular Autoimmunity. Molecular Autoimmunity
101
113
.
B-Y Xu, D Huang, R Pirskanen & A K Lefvert. (2000) β2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG). Clinical and Experimental Immunology 119:1, pages 156-160.
Crossref
Crossref
Raghavanpillai Raju, Eric Marietta, Javier Vinasco, Bianca M Conti-Fine, Anthony J Infante & Chella S David. (2002) Cryptic determinants and promiscuous sequences on human acetylcholine receptor: HLA-dependent dichotomy in T-cell function. Human Immunology 63:4, pages 237-247.
Crossref
Crossref
Francesca L Sciacca, Cinzia Ferri, Fabrizio Veglia, Francesca Andreetta, Renato Mantegazza, Ferdinando Cornelio, Diego Franciotta, Giovanni Piccolo, Vittorio Cosi, Anna P Batocchi, Amelia Evoli & Luigi M.E Grimaldi. (2002) IL-1 genes in myasthenia gravis: IL-1A −889 polymorphism associated with sex and age of disease onset. Journal of Neuroimmunology 122:1-2, pages 94-99.
Crossref
Crossref
Mathilde A Poussin, Elzbieta Goluszko, Chella S David, Juan U Franco & Premkumar Christadoss. (2001) HLA-DQ6 Transgenic Mice Resistance to Experimental Autoimmune Myasthenia Gravis is Linked to Reduced Acetylcholine Receptor-specific IFN-γ, IL-2 and IL-10 Production. Journal of Autoimmunity 17:3, pages 175-180.
Crossref
Crossref
Carani B Sanjeevi. (2000) HLA-DQ6-mediated protection in IDDM. Human Immunology 61:2, pages 148-153.
Crossref
Crossref
Jan Hillert & Anna Fogdell-Hahn. 2000. HLA in Health and Disease. HLA in Health and Disease
219
230
.
Peter Hjelmström & Carani B. Sanjeevi. 2000. Myasthenia Gravis. Myasthenia Gravis
94
104
.
Veena Taneja & Chella S. David. (2006) HLA class II transgenic mice as models of human diseases. Immunological Reviews 169:1, pages 67-79.
Crossref
Crossref
DeRen Huang, Ritva Pirskanen, Georg Matell & Ann Kari Lefvert. (1999) Tumour necrosis factor-α polymorphism and secretion in myasthenia gravis. Journal of Neuroimmunology 94:1-2, pages 165-171.
Crossref
Crossref
P Hjelmström, C.S Peacock, R Giscombe, R Pirskanen, A.K Lefvert, J.M Blackwell & C.B Sanjeevi. (1998) Polymorphism in tumor necrosis factor genes associated with myasthenia gravis. Journal of Neuroimmunology 88:1-2, pages 137-143.
Crossref
Crossref
Raghavan Raju, Wen-Zhi Zhan, Peter Karachunski, Bianca Conti-Fine, Gary C. Sieck & Chella David. (1998) Polymorphism at the HLA-DQ Locus Determines Susceptibility to Experimental Autoimmune Myasthenia Gravis. The Journal of Immunology 160:9, pages 4169-4174.
Crossref
Crossref
P. HJELMSTROM, C. S. PEACOCK, R. GISCOMBE, R. PIRSKANEN, A. K. LEFVERT, J. M. BLACKWELL & C. B. SANJEEVI. (1998) Myasthenia Gravis with Thymic Hyperplasia Is Associated with Polymorphisms in the Tumor Necrosis Factor Region. Annals of the New York Academy of Sciences 841:1 MYASTHENIA GR, pages 368-370.
Crossref
Crossref
P Hjelmström, C DeWeese-Scott, J.E Penzotti, T.P Lybrand & C.B Sanjeevi. (1998) Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling. Journal of Neuroimmunology 85:1, pages 102-105.
Crossref
Crossref
DeRen Huang, Ritva Pirskanen, Peter Hjelmström & Ann Kari Lefvert. (1998) Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis. Journal of Neuroimmunology 81:1-2, pages 76-81.
Crossref
Crossref
Farid Djabiri, Sophie Caillat-Zucman, Philippe Gajdos, Jean-Philippe Jaı̈s, Lucienne Gomez, Iman Khalil, Dominique Charron, Jean-François Bach & Henri-Jean Garchon. (1997) Association of the AChRα-subunit Gene (CHRNA), DQA1*0101, and the DR3 Haplotype in Myasthenia Gravis. Evidence for a Three-gene Disease Model in a Subgroup of Patients. Journal of Autoimmunity 10:4, pages 407-413.
Crossref
Crossref
P. Hjelrnström, R. Giscombe, A. K. Lefvert, R. Pirskanen, I. Kockum, M. Landin‐Olsson & C. B. Sanjeevi. (2008) TAP polymorphisms in Swedish myasthenia gravis patients. Tissue Antigens 49:2, pages 176-179.
Crossref
Crossref